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INTRODUCTION
Sepsis kills. With an estimated annual mortality of 30 -50 per 
100,000 population, although survival has slightly increased in the 
past 10 - 15 years (1) (2). It affects 18 million people worldwide 
every year and ranks in the top 10 causes of death with annual 
treatment costs in the US alone of over $16 billion (3).
SIRS
Two or more of:
Temperature >38°C or <36°C
Tachycardia >90 beats per minute
Respiratory rate >20 breaths per minute or PaC02
<4.3kPa
White Blood cell count >12 x 109/L or <4 x 109/L or
>10% immature (band) forms
Sepsis SIRS due to infection
Severe Sepsis Sepsis with evidence of organ hypoperfusion
Sepbic Shock
Severe sepsis with hypotension (systolic blood
pressure < 90mmHg) despite adequate fluid
resuscitation or the requirement for vasopressors /
inotropes to maintain blood pressure
Table 1: Clinical definitions for the systemic inflammatory response 
syndrome (SIRS) and sepsis (4)
Sepsis, originally defined as putrification or decomposing of organic 
matter by micro-organisms (5), is the body's systemic response to 
infection. Consensus was reached with regards to clinically defining 
the condition in 1992 (table 1) (4) with the list of signs and 
symptoms increased in 2001 (6) and a simple haematological 
investigation has recently been shown to aid early diagnosis (7) . 
However, these clinical criteria for the diagnosis of sepsis do not 
discriminate differences in underlying pathophysiology, thus 
hindering development and application of effective targeted therapies 
(8) (9) (10) (11).
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The systemic inflammatory states of sepsis, septic shock and 
endotoxaemia affect most organs of the body including white adipose 
tissue with lipolytic activity and glucose metabolism particularly 
affected (12) (13) . It is well established that glucose utilization 
is impaired and lipolysis altered in obesity, inflammation and sepsis 
(14) (15).
However, it has recently come to light that white adipose tissue 
(WAT), the body's main insulator and energy store, plays a mediatory 
role not confined to just glucose and fat metabolism and is a major 
endocrine secretory organ. WAT, by secreting protein mediators and 
signalling factors coined adipokines (16), contributes to 
inflammation related conditions in obesity such as the metabolic 
syndrome (17) (18).
Obesity is now a major health concern worldwide and has been 
described as an epidemic (19) (20) . However, for obese ICU patients 
there appears to be a conundrum or even paradox with respect to 
outcomes. Obese patients were initially shown to have a poorer 
outcome from critical illness compared to non-obese patients (21-23) 
(24), but recent meta-analyses (25) (26) have suggested the reverse. 
But this is probably not the whole story, as a series of potential 
confounders may have affected these results (27)and indeed it may be 
the location of fat depots is a better predictor (28). Obese patients 
are still more difficult to manage due to difficulties and 
complications of ventilation and the high incidence of serious 
comorbidities such as ischaemic heart disease and diabetes.
As adipose tissue mass expands the concentration of a number of 
adipokines and proinflammatory markers expressed and secreted by 
adipocytes has been shown to rise. These include - cytokines (e.g. 
IL-6, IL-10), chemokines (e.g. IL-8, MCP-1, MIF) and acute-phase 
proteins (e.g. haptoglobin, serum amyloid A) as well as inflammation-
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related adipokines such as leptin and nerve growth factor (NGF) (17)
(18) (16) (29). These inflammatory responses may reflect hypoxia in 
the growing adipose tissue mass. Hypoxia is known to induce cytokine 
production in organs such as heart, kidneys and gut (30) . Sepsis 
involves general microvascular dysfunction causing a decrease in 
oxygen delivery, producing tissue hypoxia and organ dysfunction (31). 
The recognition and appropriate response of cells to hypoxia is 
substantially mediated by the hypoxia inducible factor-1 (HIF-1) 
transcriptional system (32) (30, 33). Activation of HIF-1 during 
hypoxia, by stabilization of the HIF-lot subunit, triggers expression 
of glycolytic enzymes and membrane glucose transporters, such as 
GLUT-1 (32). HIF-lot was discovered more than 20 years ago when the 
expression of erythropoietin was being studied (34) . It rapidly 
became clear that HIF-la is a key regulator of many other systems and 
it is now apparent that certain cytokines and growth factors can make 
use of this 'hypoxic signaling system7 under normoxia (35). Some of 
these responses are amplified in the presence of hypoxia (36) . There 
appears to be distinct signalling pathways, induced by hypoxia or 
Toll-like receptor 4 mediated, for HIF-la stabilisation leading to 
differential gene expression (37).
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RESEARCH QUESTION
It was hypothesized that in endotoxaemia there is a major activation 
of the inflammatory response in adipose tissue, key inflammatory 
adipokines contributing to the metabolic dysregulation characteristic 
of endotoxaemia and sepsis. I used murine models of endotoxaemia and 
polymicrobial (surgical) sepsis to study the expression in both 
internal and subcutaneous adipose tissue of a series of inflammation- 
related adipokines. Evidence for the induction of adipose tissue 
hypoxia was sought through measurement of HIF-la.
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MODELS OF SEPSIS
Sepsis is a complex disease, affecting multiple organ systems, and 
frequently requires intensive care. The average age of patients is 60 
- 65 years and it is more common in men (38) with higher mortality 
with increasing age (3) . Severe sepsis has long term (>6 months) 
effects on both mental and physical health (39).
As well as treating the underlying infection with appropriate 
antibiotics and surgery etc, the patient often needs heamodynamic and 
respiratory support. This includes the use of sedative, analgesic, 
inotropic, steroid and other medication. Frequent observation and 
continuous invasive monitoring of vital signs are used to guide 
treatment.
KEY FEATURES OF A MODEL:
Standardisation - in order to minimise individual differences and 
genetic polymorphisms responsible for the spectrum of responses seen 
in human sepsis (40) and ensure all subjects experience identical 
conditions. Hence, animals should be of the same strain, age, weight 
and experience identical husbandry conditions and the intervention 
should be of a standard dose for each arm of the study.
The procedures performed should be easily reproducible and hence 
reduce any operator variability. Effects of the model need to be 
clearly measurable which could be by direct observation, invasive / 
non-invasive monitoring and laboratory tests. Ultimately, the model 
needs to be valid - i.e. produce a definite septic response due to 
polymicrobial contamination or endotoxaemia etc. The actual model 
should also be as simple and cost effective as possible and use the 
least number of subjects to answer the question.
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MODELS USED:
There are mainly two widely used models:
1. Injection, either intraperitoneal or intravenous, of bacteria 
or bacterial contents (e.g. LPS) . These are simple methods 
that can be used to produce endotoxaemia or sepsis due to 
specific organisms (41).
2. The release of faeces into the peritoneal cavity by caecal 
ligation and puncture (CLP) or ascending colon stent 
peritonitis. These are the preferred methods to model the
polymicrobrial insult of surgical / perioperative sepsis (41) 
(42, 43).
AIMS:
To manage the complexity and demonstrate specific biological 
dysfunction in systems in order to gain a better understanding of the 
pathophyisology (Fig.l).
LIMITATIONS OF MODELS
Models by their nature are a controlled artificial environment with a 
set of specified procedures that in themselves can effect the 
outcome. Anaesthesia, which was a requirement of our licence, can 
effect onset and survival after LPS injection (44) and opiates, which 
were used in the CLP work, may alter the immune response (45) . 
However, deep sedation incorporating opiates is used in the clinical 
management of patients with severe sepsis.
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SEPSIS
Manage complexity
MODEL
O
Measured system variables
L- - - - - - - - - - - - - - - - - - - - - - - - - - -
INSIGHT into PATHOPHYSIOLOGY 
and THERAPY
Fig 1: Aims of a model of sepsis
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LEGAL REQUIREMENTS
IN ACCORDANCE WITH ANIMALS (SCIENTIFIC PROCEDURES) ACT 1986 THE 
SPECIFIC LICENCES UNDER WHICH WORK PERFORMED:
PROJECT LICENCE : PPL 40/2692
PERSONAL LICENCE : PIL 40/7646
In the first round of experiments both models have been 
implemented:
1. PRELIMINARY CLP (SURGICAL SEPSIS) AND LPS 
(ENDOTOXAEMIA) WORK
Caecal ligation and puncture produces a polymicrobial insult more 
akin to that seen in sepsis due to traumatic injury or surgery (42,
43) .
METHOD
After obtaining a Home Office licence, we investigated thirty-two 
healthy, 8-10 week old, inbred, non-obese, male C57BL/6J mice 
(obtained from Charles River, UK) (body wt. 25-28 g) . Eight animals
served as controls; in eight animals, sepsis was induced by caecum 
ligature/puncture (CLP), in another eight animals by intra-peritoneal 
LPS injection (25 ^ig/g body wt) and eight animals were sham-operated. 
Twenty-four hours after induction of sepsis, the experimental animals 
were killed and RNA extracted from the epididymal fat pads (Fig.8). 
Real time PCR (see later experimental protocol) was used to quantify 
expression of IL-6, TNFa , IL-18, MCP-1, nerve growth factor (NGF),
hypoxia-induced factor (HIF-la), adipsin, adiponectin and leptin, in 
comparison to controls.
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CLP SURGICAL PROTOCOL
The mouse was weighed and anaesthetised (see separate protocol).
The mouse was positioned on a cork board using loops of micropore 
tape (only need to tape lower limbs) and a heating mattress placed 
under the board. The abdomen was shaved (hovering the shaved fur) 
and cleaned with aqueous, not alcoholic, iodine solution.
A midline abdominal incision was made using small scissors and opened 
in 2 layers - being careful not to damage bowel.
The caecum was exposed - cotton buds are useful to aid retraction and 
move bowel (the abdomen of sham operated animals would be closed at 
this point as described below).
Once mobilised the caecum was tightly ligated with a silk tie at the 
base.
The caecum was punctured twice with a 21G needle, distal to the ties, 
and squeezed to expel some of its contents.
The abdomen was closed in 2 layers with 4/0 Dexon - peritoneum and 
musculature with a continuous suture and skin with interrupted 
sutures.
The mouse was given a subcutaneous injection of 1ml warmed 0.9% 
Saline.
Analgesia was provided, anaesthesia reversed, and post op care 
provided as described in the separate protocol.
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ANAESTHESIA PROTOCOL
The mouse was placed in the anaesthetic chamber and general 
anaesthesia induced with 1-2% isoflurane (Abbott, uk) in nitrous 
oxide / oxygen mixture (N20/02/IS0).
Once anaesthetised the mouse was removed from chamber and injected 
with:
• Ketamine 75mg/kg - 0.2ml of 1:10 dilution
• Medetomidine Img/kg - 0.3ml of 1:10 dilution (reduce to 0.2ml 
if weighs <25g)
Supplemental oxygen was provided while the injectable anaesthetic 
took effect.
REVERSAL
The mouse was administered an Antisedan injection - 0.1ml sc of a
1:10 dilution.
POST-OP ANALGESIA
Analgesia was provided by an injection of Buprenorphine - 0.15ml sc 
of 1:20 dilution
POST-OP CARE
The mouse was given a fluid bolus of 1ml 0.9% Saline sc to the scruff 
and placed on bubble wrap mattress in an incubator with 2L /min 02. 
The incubator temperature was monitored - aiming to maintain -30-32 C 
(heating mattress may need turning of and on) and the mouse turned 
frequently - - 30 minutely intervals. It was transferred to an 
individual cage when became mobile. Further fluid boluses 0.5ml 0.9% 
Saline sc were administered as required (if lethargic). The mice were 
monitored regularly by a trained anaesthetist as per license 
requirements.
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LPS PROTOCOL
24Hr LPS
The mouse was weighed.
The mouse was placed in the anaesthetic chamber and general 
anaesthesia induced with 1-2% isoflurane (Abbott, uk) in nitrous 
oxide / oxygen mixture (N20/02/IS0).
Once deeply anaesthetised 600 pg of LPS (Escherichia coli O 
Sigma-Aldrich) was injected ip (0.3ml) - 25pg / g
To compensate for fluid loses 1ml of Saline was administered sc to 
the scruff.
Analgesia was provided by giving Buprenorphine injection sc 0.15ml of 
1:20 dilution.
Post procedure the mice were housed in separate clean cages and 
maintained in the same temperature controlled (24-28°C) conditions 
with free access to standard laboratory chow and water.
Repeat fluid boluses were administered as indicated.
SAMPLE COLLECTION
24 hours post procedure all animals were killed by the schedule 1 
method of rising concentration of carbon dioxide.
The fat deposits were removed and immediately frozen in liquid 
nitrogen and stored at -80°C until further analysis.
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RESULTS
Twenty-four hours after induction of sepsis by LPS, real time PCR 
revealed substantial increases in the expression of IL-6 (500-fold), 
MCP-1 (55-fold), NGF (10-fold), TNE^ (5-fold) and HIF-lot (3-fold), 
while there were significant decreases in the expression of IL-18 
(2.5-fold), adipsin (6-fold) and adiponectin (5-fold). The results in 
the CLP-group were qualitatively similar.
The work in these first set of experiments was presented 
as a poster (see appendix) at 2nd International Congress 
of the German Sepsis Society (GSS) in Weimar, Germany , 
September 7 - 10 , 2005.
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Fig. 2 Adipokine gene expression in sepsis and endotoxaemia. Twenty- 
four hours after induction of sepsis by CLP (blue bars) and 
endotoxaemia (red bars) or sham lapaparotomy (turquoise bars) 
surviving animals were killed by a rising concentration of C02 and 
the epididymal fat depots removed. The level of each adipokine mRNA 
was measured by real-time PCR and normalized to (3-actin relative to 
the untreated control group (=1). Real time PCR revealed significant 
decreases in the expression adipsin and adiponectin which were 
qualitatively similar in both the CLP and LPS groups.
Results are given as mean values ± SE for five to six mice in each 
group. *F<0.05, **P<0.01, ***P<0.001 compared with controls.
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Fig. 3 T Adipokine gene expression in sepsis and endotoxaemia. 
Twenty-four hours after induction of sepsis by CLP (blue bars) and 
endotoxaemia (red bars) or sham lapaparotomy (turquoise bars) 
surviving animals were killed by a rising concentration of C02 and 
the epididymal fat depots removed. The level of each adipokine mRNA 
was measured by real-time PCR and normalized to (3-actin relative to 
the untreated control group (=1) . In the LPS group real time PCR 
revealed a substantial increase in the expression of MCP-1 (55-fold, 
while there was a significant decrease in the expression of IL-18 
(2.5-fold). The results in the CLP-group were qualitatively similar. 
Results are given as mean values ± SE for five to six mice in each 
group. *P<0.05, **P<0.01, ***P<0.001 compared with controls.
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Fig. 4 Adipokine gene expression in sepsis and endotoxaemia. Twenty- 
four hours after induction of sepsis by CLP (blue bars) and 
endotoxaemia (red bars) or sham lapaparotomy (turquoise bars) 
surviving animals were killed by a rising concentration of C02 and 
the epididymal fat depots removed. The level of each adipokine mRNA 
was measured by real-time PCR and normalized to (3-actin relative to 
the untreated control group (=1). Real time PCR revealed substantial 
increases in the expression of IL-6 (500-fold), and HIF-la (3-fold)in 
the LPS group with qualitatively similar results in the CLP-group. 
Results are given as mean values ± SE for five to six mice in each 
group. *P<0.05, **P<0.01, ***P<0.001 compared with controls.
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Fig. 5 Adipokine gene expression in sepsis and endotoxaemia. Twenty- 
four hours after induction of sepsis by CLP (blue bars) and 
endotoxaemia (red bars) or sham lapaparotomy (turquoise bars) 
surviving animals were killed by a rising concentration of C02 and 
the epididymal fat depots removed. The level of each adipokine mRNA 
was measured by real-time PCR and normalized to p-actin relative to 
the untreated control group (=1) . Real time PCR revealed substantial 
increases in the expression of NGF (10-fold) and TNF„ (5-fold)in the 
LPS group with results in the CLP-group being qualitatively similar. 
Results are given as mean values ± SE for five to six mice in each 
group. *P<0.05, **P<0.01, ***P<0.001 compared with controls.
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2. REFINED LPS MODEL (ENDOTOXAEMIA)
Intraperitoneal injection of LPS was used which produces 
endotoxaemia. The efficacy had been proven from the preliminary work 
(see first set of experiments).
Further refinements were made to initial experimental model :
No opiates were used as they could effect inflammatory response (45).
The organs were harvested after cervical dislocation to minimise 
premortem hypoxia (compared to rising concentration of C02).
As no laparotomy was performed there was no potential influence from 
the surgical trauma.
Confounding factors were reduced by using a single sex (male to 
exclude the oestrous cycle), strain of mice, and a single operator 
performing all procedures. Baseline and control groups were included 
to assess if the stress of the new environment for the mice had an 
effect. A mixture of procedures performed each day - as mice for 
different days could have been from different batches.
More fat depots were collected and analysed for more markers than in 
the previous set of experiments.
These experiments have led to a publication (46) in 
Pflugers Archiv European journal of physiology which 
itself has been regularly cited - now (December 2012) by 
over 20 articles (see appendix for list and copy of 
paper).
21
LPS METHOD
Male 8-10 week old, inbred, C57BL/6J mice (obtained from Charles 
River, UK) were used in all experiments.
Mice were kept in the animal house for at least one week prior 
procedures, as per departmental protocol, to assure fitness.
The care of the mice and all experimental procedures were approved by 
the UK Home Office and were conducted in accordance with the 
appropriate Project License.
The mice were weighed prior to the procedure.
Anaesthesia was induced with 1-2% isoflurane (Abbott, uk) in nitrous 
oxide / oxygen mixture (N20/02) and maintained with the same agents.
Prior to injection the proposed site was cleaned with iodine 
solution.
LPS (Escherichia coli O 111:B4, Sigma-Aldrich) was injected 
intraperitoneally (ip) under general anaesthesia at a dose of 25 
mg/kg.
Control animals were administered equivalent volumes of normal 
saline, ip.
All animals received 1 ml of normal saline subcutaneously (sc) to 
compensate for fluid losses.
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Post procedure the mice were housed in separate clean cages and 
maintained in the same temperature controlled (24-28°C) conditions 
with free access to standard laboratory chow and water.
The animals were exposed to the same standard 12 hour day / night 
conditions.
The mice were monitored regularly by a trained anaesthetist as per 
license requirements.
All mice were killed at 4 or 24 hours after the injection of LPS by 
cervical dislocation.
The epididymal, subcutaneous and perirenal fat deposits were removed 
and immediately frozen in liquid nitrogen and stored at -80°C till 
further analysis.
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LPS ip 
N/S sc 
WAKE UP
N/S ip 
N/S sc
WAKE UP
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SHAM
DIRECT FROM 
ANIMAL 
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AT 24 HOURS
BASELINE CONTROL
GENERAL ANAESTHESIA
IDENTICAL CONTROLLED CONDITIONS 
FOR 4 OR 24 HOURS
SCHEDULE 1 AND TISSUE COLLECTION
HEALTHY ADULT MICE
Fig.6: Flow diagram of procedures for the LPS model
LPS = Lipopolysacharide, ip = intraperitoneal, sc = 
subcutaneousr N/S = Normal (0.9%) saline
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RNA EXTRACTION AND PCR
Total RNA was isolated from the adipose tissues using Trizol reagent 
(Invitrogen, UK).
Extracted RNA was quantified spectrophotometrically at 260 nm. Ratio 
of extinction at 260 and 280nm was between 1.7 and 1.9, and the 
quality was assessed by visualization of 18s and 28s ribosomal bands 
on an agarose gel.
1 pg of DNase I-treated RNA was reverse transcribed using a Reverse- 
iT™ 1st Strand Synthesis Kit (Abgene, UK) in the presence of anchored 
oligo dT in a total volume of 20 pi. on a PCR Express thermal Cycler 
(Hybaid, Ashford, UK) . Controls without reverse transcription were 
performed to exclude the possibility of DNA contamination.
Real-time polymerase chain reaction {PCR) reactions were carried out 
in a final volume of 12.5 pi consisting of 12.5-50 ng of reverse 
transcribed cDNA mixed with optimal concentrations of primers and 
probe and qPCR™ Core kit (Eurogentec, UK) in 96-well plates on a 
Mx3005P detector {Stratagene, USA) . The primer and probe sets were 
designed using Primer Express software (Applied Biosystems) or Beacon 
Designer (Biosoft, USA) and synthesized commercially (Eurogentec). 
The sequence of primers and probes is shown in Table 2. Typically, 
the amplification started with 10 min at 95°C and then 40 cycles of 
the following: 15 s at 95°C and 1 min at 60°C. (3-actin was used as an 
endogenous reference. Relative quantitation values were expressed 
using the 2-AACt method (see User bulletin #2, ABI Prism 7700, 
Applied Biosystems) as fold changes in the target gene normalized to 
the reference gene and related to the expression of the controls. The 
PCR efficiency in all runs was close to 100%, and all samples were 
analyzed in at least duplicate.
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Gene Sequence 5'-3'
Adiponectin Forward GGCTCTGTGCTCCTCCATCT
Reverse AGAGTCGTTGACGTTATCTGCATAG
Probe CCCATACACCTGGAGCCAGACTTGGT
Adipsin Forward ACGACCTCATTCTTTTTAAGCTATCC
Reverse CCGGGTTCCACTTCTTTGTC
Probe TCCCCACGTGAGACCCCTACCCTT
p-actin Forward GAAGAAGGAAGGCTGGAAAAG
Reverse ACGGCCAGGTCATCACTATTG
Probe ACGAGCGGTTCCGATGCCCTG
F4/80 Forward AAGACTTGATACTCCAAAGTGAGC
Reverse GAAGGAAGCATAACCAAGATCCC
Probe CCCTGCACTGCTTGGCATTGCTGT
HIF-lct Forward CAAGTCAGCAACGTGGAAGGT
Reverse CTGAGGTTGGTTACTGTTGGTATCA
Probe TTCACTGCACGGGCCATATTCATGTC
IL-6 Forward ACAACCACGGCCTTCCCTACTT
Reverse CACGATTTCCCAGAGAACATGTG
Probe TTCACAGAGGATACCACTCCCAACAGAACCT
XL-18 Forward GGCCTCTATTTGAAGATATGACTGATT
Reverse CCTCTAGGCTGGCTATCTTTATACATACT
Probe TGACTGTAGAGATAATGCACCCCGGACC
Leptin Forward CATCTGCTGGCCTTCTCCAA
Reverse ATCCAGGCTCTCTGGCTTCTG
Probe AGCTGCTCCCTGCCTCAGACCAGTG
MAC-1 Forward GAATGGATTGTGCTATTTGTTCGG
Reverse CGGAGCCATCAATCAAGAAGAC
Probe TCCAACCTGCTGAGGCCGCCC
MCP-1 Forward GGCTCAGCCAGATGCAGTTAA
Reverse CCTACTCATTGGGATCATCTTGCT
Probe CCCCACTCACCTGCTGCTACTCATTCA
MT2 Forward CTTCTTGTCGCTTACACCGTT
Reverse AGCAGCACTGTTCGTCACTTC
NGF Forward GCCAAGGACGCAGCTTTCTAT
Rev AGTGATCAGAGTGTAGAACAACATGGA
Probe CTGGCCGCAGTGAGGTGC
TNFa Forward CCCAGACCCTCACACTCAGATC
Reverse GCCACTCCAGCTGCTCCTC
Probe TAGCCCACGTCGTAGCAAACCACCAAG
Table 2. Primer 
(46)
and probe sequences used in real time PCR (amended)
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MEASUREMENT OF PROTEIN BY ELISA
The total amount of HIF-la in adipose tissue homogenates was measured 
by enzyme-linked immunosorbent assay (ELISA) (R & D Systems, UK) as 
previously described. The adiponectin, IL-6 and MCP-1 content of 
adipose tissue homogenates was also measured using commercial ELISAs, 
according to the manufacturer's protocol. For adiponectin (R & D 
Systems), the stated minimal detectable amount was 3 pg/ml, and the 
interassay coefficient of variation was 6%. For 11-6 (RayBiotech, 
USA) , the minimal detectable quantity was 6 pg/ml and the interassay 
coefficient of variation <12%, while for MCP-1 (RayBio- tech), the 
values were <3 pg/ml and <12%, respectively.
DATA PRESENTATION AND STATS
Data are expressed as the mean ± standard error of mean. The 
statistical significance of differences between treated and control 
groups was assessed with two-tailed Student's t test for independent 
samples. A p valve <0.05 was considered to be statistically 
significant.
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RESULTS
Effect of LPS on adipokine expression 24 h after the 
induction of endotoxaemia
In order to induce severe endotoxaemia, a high dose of 
lipopolysaccharide was administered; the survival rate at 4 h was 
100%, while the 24 h survival rate was 61% [14/23] . In the first
experiments, the mice were treated with LPS for 24 h and the 
epididymal, perirenal and subcutaneous adipose tissue depots 
examined. Tissues were only analysed for those animals that survived. 
LPS administration had no significant effect on leptin mRNA level in 
the epididymal WAT; nor was there any change in metalliothein-2 mRNA 
{Fig.7). However, LPS induced a fivefold fall in adiponectin mRNA 
level, and there was a similar reduction in the level of both adipsin 
and IL-18 mRNA {Fig.7). In contrast to these genes, there were 
increases in mRNA level for IL-6, MCP-1, NGF and TNFct (Fig.7). The 
increase in NGF mRNA was small (twofold) , but MCP-1 and TNFa mRNA 
levels increased by 24- and 18-fold, respectively, while IL-6 mRNA 
level increased as much as 250-fold.
28
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Fig. 7 Adipokine gene expression in endotoxaemia in mice (46) . Mice 
were injected with LPS to induce severe sepsis (closed bars) and 
adipose tissue depots removed 24 h later; control mice (open bars) 
received a saline injection. The level of each adipokine mRNA was 
measured in epididymal (Epi) , perirenal (Peri) and subcutaneous (Sub) 
depots by real-time PCR and normalized to (3-actin relative to the 
untreated control group (=1) . IL-6 Interleukin 6, IL-18 interleukin
18, MCP-1 monocyte chemoattractant protein 1, MT2 metallothionein 2, 
NGF nerve growth factor, TNFa tumour necrosis factor a. Results are 
given as mean values±SE for five to six mice in each group. 
*P<0.05, **P<0.01, ***P<0.001 compared with controls.
Adiponectin gene expression in epididymal fat pads previously 
published in M.Phil thesis by Honggwang Bao {47}
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Examination of the perirenal adipose tissue depot gave broadly 
similar results, with reductions in adipsin and adiponectin mRNA 
levels (Fig.7) . However, the changes were less substantial than with 
the epididymal depot, the decreases in IL-18 and adiponectin mRNA 
levels being statistically insignificant. Leptin was again unchanged 
following treatment with LPS. TNFcx mRNA level increased by eightfold, 
MCP-1 by 40-fold and the largest increase (120-fold) was with IL-6 
(Fig.7) .
The results obtained with the subcutaneous adipose tissue were less 
dramatic than with either the epididymal or perirenal depots. 
Adiponectin mRNA level fell fivefold, but there were no significant 
changes with leptin, adipsin, IL-18, NGF, TNFa and MT-2 (Fig.7). The 
lack of change in TNFcx mRNA is noteworthy given the increases 
observed in the other two fat depots. MCP-1 and IL-6 mRNA levels 
were, however, elevated in subcutaneous fat in response to LPS, the 
increases being four- and 20-fold, respectively (Fig.7).
Effect of LPS on adipokine expression 4 h after the 
induction of endotoxaemia
To assess the speed of the response to LPS, studies were next
undertaken at 4 h after injection. Epididymal, perirenal and
subcutaneous adipose tissue depots were again examined. In the 
epididymal depot at 4 h, there were no significant changes in
adipsin, adiponectin, IL-18 and MT-2 mRNA levels (Fig.8). There were, 
however, small, but statistically significant, increases in leptin 
(fourfold) and NGF (3.8-fold) mRNAs. Substantial increases were
observed for TNFcx (20-fold) and particularly MCP-1 (250-fold) and IL- 
6 (500-fold) mRNA. A broadly similar pattern was observed in the
perirenal depot, although in this case, there was no change in leptin
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mRNA level. The largest changes were again with MCP-1 and IL-6 mRNA
the levels of 
(Fig.8). TNFa 
(fourfold) was
which were increased by 35- and 78 
level increased 23-fold, and 
observed with NGF.
fold, respectively 
modest increase
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Fig, 8 Acute effects of endotoxaemia on adipoklne gene expression in 
mice (46) . Mice were injected with LPS to induce severe sepsis 
(closed bars) and adipose tissue depots removed 4 h later; control 
mice (open bars) received a saline injection. The level of each 
adipokine mRNA was measured in epididymal (Epi), perirenal (Peri) and 
subcutaneous (Sub) depots by real-time PCR and normalized to p-actin 
relative to the untreated control group (=1) . Results are given as 
mean values + SE for five to six mice in each group. *P<0.05, 
**P<0.01/ ***P<0.001 compared with controls.
Adiponectin and TNFa gene expression in epididymal fat pads 
previously published in M.Phil thesis by Honggwang Bao (47)
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In the subcutaneous adipose tissue, there were no changes in mRNA 
levels for IL-18, leptin and MT-2 (Fig.8). There was, however, an 
approximately 50% reduction in mRNA levels for adipsin and 
adiponectin. NGF and TNFot mRNA levels increased moderately, by four- 
and 17-fold, respectively. Very major changes were observed with MCP- 
1, the mRNA level of which increased 250-fold, and with IL-6 where 
the increase was >1,000-fold (Fig.8).
White adipose tissue adipokine levels
The adipokine protein content was measured by ELISA in the epididymal 
and subcutaneous fat depots for the two inflammatory adipokines which 
exhibited the largest changes in mRNA level. IL-6, which showed the 
greatest elevation in mRNA, was increased in both the epididymal and 
subcutaneous fat at 4 and 24 h after the injection of LPS (Fig. 9) . 
The increase in the epididymal depot was between five- and eightfold, 
while in the subcutaneous tissue the rise was between three- and 
eightfold.
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Fig. 9 Adipokine levels in adipose tissue in endotoxaemia in mice 
(46) . Mice were injected with LPS to induce severe sepsis (closed 
bars) and adipose tissue depots removed 4 or 24 h later; control mice 
(open bars) received a saline injection. Adipokine proteins were 
measured in the epididymal (Epi) and subcutaneous (Sub) depots by 
ELISA. Results are given as mean values ± SE for three to six mice in 
each group. *P<0.05, **P<0.01 compared with controls.
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In contrast to IL-6, there was no significant increase in MCP-1 
protein in either tissue at 24 h. However at 4 h, the amount of MCP-1 
was approximately eightfold greater in the epididymal fat and twofold 
greater in the subcutaneous depot (Fig. 9). For adiponectin, only in 
the epididymal depot after 24 h of treatment with LPS was there a 
significant fall in the protein, reflecting the changes in the mRNA 
level. However, paradoxically the adiponectin level in the 
subcutaneous depot was actually increased, rather than decreased, at 
both 4 and 24 h in the LPS-treated mice.
Macrophage marker expression
To assess whether the increases in the expression of key inflammatory 
adipokine genes, particularly MCP-1, reflected an infiltration of 
macrophages into adipose tissue, the mRNA level of two macrophage 
markers was examined. The markers were F4/80 and MAC-1, and these 
were examined in 4 and 24 h LPS-treated mice and in all three WAT 
depots. In no case was there a statistically significant increase in 
F4/80 and MAC-1 mRNA level (Fig.10). Indeed, in one case, the 
perirenal tissue treated for 24 h, the level of both mRNAs was 
significantly decreased. F4/80 mRNA level was also decreased in the 
epididymal depot at 24 h.
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Fig. 10 Expression of macrophage markers in adipose tissue in 
endotoxaemia in mice (46) . Mice were injected with LPS to induce 
endotoxaemia (closed bars) and adipose tissue depots removed 4 or 
24 h later; control mice (open bars) received a saline injection. The 
level of each macrophage marker mRNA was measured in epididymal 
(Epi), perirenal (Peri) and subcutaneous (Sub) depots by real-time 
PCR and normalized to (3-actin relative to the untreated control group 
(=1) . Results are given as mean values ± SE for five to six mice in 
each group. *P<0.05, **P<0.01, ***P<0.001 compared with controls.
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HIF-la as an index of hypoxia
In the final investigation, the effect of LPS treatment on the key 
molecular index of cellular oxygen deficiency, the hypoxia-sensitive 
transcription factor HIF-la, was examined. The expression and protein 
level of HIF-la was determined in both the epididymal and 
subcutaneous adipose tissue depots. At 4 h after the treatment with 
LPS, there was a three to fourfold increase in HIF-la mRNA in each 
depot, and importantly, this was accompanied by a two to threefold 
increase in HIF-la protein (Fig.11). HIF-la mRNA level was also 
twofold higher in both depots at 24 h, but at this later time point, 
there was no significant change in HIF-la protein (Fig.11).
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Fig. 11 HIF-la gene expression and protein levels in adipose tissue 
in endotoxaemia in mice (46) . Mice were injected with LPS to induce 
endotoxaemia (closed bars) and adipose tissue depots removed 4 or 
24 h later; control mice (open bars) received a saline injection. 
HIF-la mRNA (a) and protein levels (b) were measured in the 
epididymal (Epi) and subcutaneous (Sub) depots by real-time PCR, the 
level being normalized to (3-actin relative to the untreated control 
group (=1), and by ELISA, respectively. Results are given as mean 
values ± SE for five to six mice in each group. *P<0.05, **P<0.01 
compared with controls.
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DISCUSSION
This study demonstrates that there are major changes in the 
expression of key adipokine genes in each of the main white adipose 
tissue depots in mice following the induction of endotoxaemia. The 
expression of several major inflammatory-related adipokines was 
examined, and by far the largest response was observed with IL-6 and 
MCP-1. Adipose tissue produces large amounts of IL-6 and is 
considered to be a substantial contributor to circulating levels of 
this cytokine (48, 49). Plasma IL-6 levels are increased in 
endotoxaemia as well as sepsis, and it seems likely that adipose 
tissue contributes directly to this (50-52), particularly since in 
this study the amount of IL-6 in the fat depots was increased 
alongside the increase in mRNA level. Nevertheless, it should be 
noted that the increase in protein was much less than the changes in 
mRNA level, although this could reflect rapid release of IL-6 from 
the tissue once synthesised.
The chemokine MCP-1 shows increased expression in obesity, like IL-6, 
and is linked to the recruitment of macrophages within tissues, 
including adipose tissue. Indeed, in obesity there is a major 
infiltration of macrophages into adipose tissue (53) (14). Since the 
mRNA level of two macrophage markers—F4/80 and MAC-1—did not increase 
in any of the three adipose tissue depots examined, either at 4 or 
24 h after the administration of LPS, it is unlikely that there was 
an infiltration of immune cells during the duration of endotoxaemia 
in the present work. The increased MCP-1 expression suggests that 
macrophage recruitment into adipose tissue may well occur long-term; 
however, in contrast to IL-6, no sustained elevation in MCP-1 protein 
levels was evident in adipose tissue homogenates following LPS
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treatment.
In addition to macrophage infiltration, MCP-1 has been associated 
with the development of insulin resistance (54). This is also the 
case with IL-6 and TNFa (55) (56-58). Thus, the major stimulation of
the expression of these three factors in response to LPS suggests 
that adipose tissue may contribute to insulin insensitivity and the 
dysregulation of glucose homeostasis in infection. TNFa is a 
pleiotrophic pro-inflammatory cytokine, and its actions in adipose 
tissue include the stimulation of lipolysis and of apoptosis (59) 
(60). It also has a major effect on the expression of other 
inflammation-related adipokines including the strong upregulation of 
IL-6 and MCP-1 production (61, 62).
In marked contrast, adiponectin expression was downregulated in all 
three adipose tissue depots 24 h after the administration of LPS. 
There was also a significant reduction in adiponectin mRNA in the 
subcutaneous depot at 4 h. Adiponectin, which is a key adipocyte- 
derived hormone, has multiple physiological effects, and these 
include anti-inflammatory and insulin sensitising actions (63-66). 
Thus, a fall in adiponectin expression may add to the upregulation of 
IL-6, MCP-1 and TNFa expression in leading to a major pro- 
inflammatory response and insulin resistance in endotoxaemia. 
However, although adiponectin protein level decreased in the 
epididymal depot at 24 h (the absence of a change at 4 h may reflect 
the time delay between alterations in gene transcription and 
subsequent protein synthesis), in the case of the subcutaneous depot, 
there was a paradoxical increase in the amount of the hormone. We 
have no satisfactory explanation for this anomaly, although it may 
indicate that adiponectin is less readily released from the 
subcutaneous adipose tissue in endotoxaemia.
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Furthermore, low adiponectin levels observed in obesity (67) as a
state of low-grade chronic inflammation are associated with increased 
insulin resistance (63, 66) Low adiponectin levels on admission to 
the intensive care unit have also been identified as an independent 
predictor of survival (68). Stress-induced hyperglycaemia frequently 
occurs in infection and is associated with an adverse outcome (69) 
(70). Elevated TNFcx levels, increased MCP-1 production as well as low 
adiponectin may act in concert to induce and to maintain 
hyperglycaemia in critical illness. Although this study does not 
reveal the extent to which adipose tissue might contribute 
quantitatively to alterations in circulating levels of cytokines and 
chemokines in endotoxaemia, overall, the results suggest a role for 
the tissue in the changes in glucose metabolism associated with 
infection. It is emphasised that since in the 24-h studies there was 
a distinct mortality rate (39%) and that only tissues from surviving 
animals were investigated, there could be a link between the gene 
expression profile and the protective survival response.
Expression of the complement-related factor, adipsin, also fell 
during endotoxaemia. Leptin, on the other hand, showed no changes in 
gene expression. This is in contrast with previous studies in 
experimental animals and in humans where an upregulation has been 
described (50, 71) (72) . However, the previously reported changes in 
leptin mRNA were very small, particularly in comparison with the 
dramatic changes in IL-6 and MCP-1 mRNA level.
Small increases in NGF mRNA level were observed in the epididymal and 
perirenal depots but not in the subcutaneous tissue. This target- 
derived neurotrophin is also involved in the inflammatory response, 
its expression and secretion from both murine and human adipocytes 
being stimulated by TNFa (73) (61). The low molecular weight
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cysteine-rich, metal-toinding protein metallothionein showed little 
response to LPS except in the perirenal depot where there was a small 
increase at 24 h. Similarly, there was little change in the 
expression of IL-18; this pro-inflammatory cytokine plays an 
important role in innate and acquired immunity, and its expression in 
adipocytes (74, 75) has been shown to be strongly upregulated by TNFa 
(75) .
Certain depot-specific responses to LPS were evident in this study. 
Of the three adipose tissue sites examined, the largest response was 
observed in the epididymal depot in the case of both IL-6 and TNFa 
(at 24 h). Indeed, the subcutaneous depot showed no increase in TNFa 
mRNA level at 24 h. In this context, it has been shown that 
subcutaneous adipose tissue is affected to a lesser degree by sepsis- 
induced malperfusion than the splanchnic area and does not contribute 
to lactate production during critical illness (15).
In addition to depot differences, there is the important question of 
which cells within adipose tissue may be responsible for alterations 
in adipokine/cytokine production in endotoxaemia. White fat consists 
of two major components, mature adipocytes and the stromal-vascular 
fraction. The stromal-vascular fraction includes macrophages, 
fibroblasts, vascular endothelial cells and preadipocytes. Adipocytes 
are able to express each of the inflammation-related signals examined 
in the present study (see (16) (29)), However, while the key 
cytokines and chemokines are also expressed by macrophages, 
adipocytes alone are responsible for adiponectin and leptin 
production.
It could be hypothesized that during endotoxaemia, macrophages 
infiltrate adipose tissue, causing further inflammatory damage and 
substantially contributing to mediator production. This would imply
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that immigrating immune cells are mainly responsible for the changes 
observed. However, as noted earlier, the mRNA level of two specific 
macrophage markers did not increase in WAT and even decreased in the 
case of the perirenal depot at 24 h. This suggests that mature 
adipocytes may be the key site of the response to LPS. Indeed, 
adipocytes express the Toll-like receptor 4 through which LPS exerts 
its inflammatory effect (76) (77). Irrespective of the cell type 
involved, adipose tissue can be regarded as a key inflammatory organ, 
which may contribute to the systemic response observed during 
systemic infection by generating and releasing inflammatory mediators 
into the circulation. However, the possibility that resident 
macrophages are activated and may contribute to adipokine/cytokine 
production in the various adipose tissue depots in endotoxaemia, 
without increased immune cell infiltration, cannot be excluded. It 
would be useful to investigate the adipose tissue using 
immunohistochemisty techniques that are able to preserve the 
architecture of the tissue to help answer the question.
It has recently been proposed that the inflammation that occurs in 
adipose tissue in obesity may, at least in part, be a response to 
relative hypoxia in groups of adipocytes distant from the vasculature 
(16). Evidence in support of this hypothesis is emerging (78) (79) 
(80), and hypoxia has been shown to directly increase the expression 
and release of inflammation-related adipokines such as leptin, IL-6, 
MIF and VEGF in murine and human adipocytes, while adiponectin with 
its anti-inflammatory action is decreased (81) (78) (82) (83) (80). 
We were therefore interested in whether hypoxia might underlie the 
changes in adipokine expression in endotoxaemia and hence fat depots 
were harvested after cervical dislocation to minimise premortem 
hypoxia (compared to rising concentration of C02) . Increases in the 
mRNA encoding the hypoxia-sensitive transcription factor, HIF-la,
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were evident following administration of LPS, and increased HIF-lcx 
protein was found at 4 h. This suggests that at least in the early 
stages of endotoxaemia, hypoxia may occur in adipose tissue. The 
changes at the protein level were not sustained by 24 h, implying 
that any hypoxia may have been transitory. However, direct HIF-lor 
gene activation by LPS, in a Toll-like receptor 4 manner, has been 
shown in macrophages (84) (85). Further work is therefore warranted 
on hypoxia in adipose tissue in severe infection and whether it 
underlies the changes in adipokine expression or if it is by direct 
stimulation by LPS / bacterial components. It may be possible to 
investigate this using gene arrays to look for specific gene 
expression profiles (37) at different time intervals.
A high dose of LPS was employed to induce endotoxaemia, and it may 
also reflect sepsis. However, the LPS challenge may not adequately 
reproduce the complexity of human sepsis. In particular, 
investigators with an interest in peri-operative sepsis have 
increasingly used caecal ligation and puncture (CLP) as the model of 
choice. In the series of experiments with CLP in the same strain of 
mice, it was possible to reproduce the changes in IL-6 mRNA levels 
found in the epididymal fat depot after LPS challenge. Here IL-6 mRNA 
levels were 87-fold higher than in control mice and sixfold higher 
than in sham-operated mice at 24 h. Apparently, CLP leads to 
qualitatively similar changes in IL-6 expression as LPS, suggesting 
that white adipose tissue is activated in septic shock as in 
endotoxaemia.
Clinical sepsis is commonly polymicrobial, but experimentation 
involving bacterial products, such as LPS, may serve to characterize 
response patterns directed against one particular organism (42). LPS 
was therefore used as the model of choice to examine the potential
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role of WAT during severe infection. The dose employed, although 
high, is within the range used in previous studies and elicited a 
severe, acute, systemic inflammatory response in mice with all the 
symptoms of sepsis and septic shock (86) . Importantly, the 
substantial increase in IL-6 and MCP-1 gene expression in the 
subcutaneous adipose tissue at 4 h indicates a systemic response in 
WAT rather than an effect local to the i.p. site of injection. The 
mortality rate of 39% in the 24-h series of experiments reflects 
acute life-threatening gram-negative infection of a severity similar 
to that occurring in human sepsis (3). Further investigations using 
various models of sepsis are warranted to specify the role of WAT in 
infection caused by different organisms.
In conclusion, the results demonstrate that an LPS challenge 
sufficient to mimic endotoxaemia leads to major changes in the 
expression of key adipokine genes in different adipose tissue depots 
of mice. Thus, white adipocytes (and preadipocytes) may well 
contribute directly to the most prominent features of infection — 
systemic inflammation and metabolic dysregulation. If this could be 
corroborated in studies involving human patients and their various 
fat depots, it would allow a new interpretation of the correlation 
between body mass index and sepsis mortality as well as the 
development of novel approaches to treating insulin resistance in 
severe infection. It is evident from our results that not all fat is 
equal and it would be valuable to investigate the differences between 
depots in the human population with samples obtained at laparotomy in 
patients with sepsis or chronic inflammatory states such as 
pancreatitis. It may also be possible to look for hypoxic responses 
in these tissues using gene arrays. Quantification of the size of 
various fat depots in septic ITU patients from their CT images and 
their possible relation to outcome would also be interesting.
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APPENDIX
LPS MOUSE EXPERIMENTS
MOUSE
NUMBER WEIGHT
EXPT
LENGTH PROCEDUE SURVIVAL OTHER
1 24g 24 LPS Y
2 25.4g 24 LPS Y
3 25.5g 24 LPS Y
4 24.6g 24 SALINE Y
5 24.6g 24 SALINE Y
6 25g 24 SALINE Y
7 22.8g 24 CONTROL Y
8 24.5g 24 CONTROL Y
9 25.8g 24 CONTROL Y
10 24 BASLINE Y
11 24 BASLINE Y
12 24 BASLINE Y
13 27.5g 24 LPS Y
14 23g 24 LPS Y
15 24.5g 24 LPS N
DIED 11HOURS
AFTER THE
INJECTION
16 26.5g 24 SALINE Y
17 24g 24 SALINE Y
18 23g 24 SALINE Y
19 22g 24 CONTROL Y
20 24g 24 CONTROL Y
21 25g 24 CONTROL Y
22 26g 24 BASLINE Y
23 26.4g 24 BASLINE Y
24 23.4g 24 BASLINE Y
25 26.6g 24 LPS Y
26 23.9g 24 LPS N
DIED 21HOURS
AFTER THE
INJECTION
27 23.5g 24 LPS Y
28 25.4g 24 LPS N
DIED 19 HOURS
AFTER THE
INJECTION
29 24.5g 24 SALINE Y
30 26g 24 SALINE Y
31 24.9g 24 CONTROL Y
32 24g 24 CONTROL Y
33 24 BASLINE Y
34 24 BASLINE Y
35 27g 4 LPS Y
36 22.4g 4 LPS Y
37 25.4g 4 SALINE Y
38 24.9g 4 SALINE Y
39 26.7g 4 CONTROL Y
40 24.5g 4 CONTROL Y
41 23.5 4 LPS Y
42 26.5 4 LPS Y
43 21.5 4 SALINE Y
44 24 4 SALINE Y
45 22.5 4 CONTROL Y
46 24.5 4 CONTROL V I 
48
47 25.5 4 LPS Y 4 Hours later weight25.9
48 24 4 LPS Y 4 Hours later weight23.3
49 23 4 SALINE Y 4 Hours later weight22.9
50 26 4 SALINE Y 4 Hours later weight26.2
51 25 4 CONTROL Y 4 Hours later weight24.4
52 24.5 4 CONTROL Y 4 Hours later weight23.4
Schedule
1
DREW BLOOD BY 
CARDIAC PUNCTURE 
UNDER GA
Schedule
1
DREW BLOOD BY 
CARDIAC PUNCTURE 
UNDER GA
53 24.5 24 LPS N DIED 20 HOURSAFTER INJECTION
54 26.7 24 LPS Y
55 24.8 24 LPS Y
56 24.8 24 LPS N DIED 17.5 HOURS AFTER INJECTION
57 26.4 24 LPS Y
58 24.5 24 LPS N DIED 18 HOURSAFTER INJECTION
59 28.7 24 SALINE Y
Large cystic tumour in 
abdomen - SAMPLES 
NOT TAKEN
60 25 24 SALINE Y
61 25.1 24 SALINE Y
62 26 24 SALINE Y
63 26.4 24 LPS N DIED 14 HOURSAFTER INJECTION
64 26.4 24 LPS Y
65 25.3 24 LPS Y
66 24.1 24 LPS Y
67 26.4 24 LPS N DIED 19.5 HOURS AFTER INJECTION
68 26.9 24 LPS Y
69 26.5 24 LPS N DIED 17 HOURSAFTER INJECTION
70 25 24 SALINE Y
71 26.5 24 SALINE Y
72 25.1 24 SALINE Y
49
European Journal of Anaesthesiology:
May 2005 - Volume 22 - Issue - p 177 
Intensive Care Medicine
A-683
A possible role of white adipose tissue in sepsis
M. Leuwer, G. Marx, A. Rushton, A. Axon, G. Masterson, L. Hunter, P. Trayhurn 
Department of Anaesthesia, The University of Liverpool, Liverpool,
United Kingdom
Background and Goal of Study: It has recently been established that white adipose tissue, besides its metabolic role, storing and 
releasing fatty acids, has a major role in secreting a variety of hormones and mediators which are referred to as adipokines.(l)
In particular, it has been suggested that adipose tissue releases pro- inflammatory cytokines, e.g. IL-6 in response to hypoxia. Thus 
we felt tempted to investigate how adipokine expression relates to sepsis in an ani- mal model.
Methods: After obtaining a Home Office licence under the Animal Rights Act, we investigated sixteen healthy, non-obese male mice 
(body weight 25-28 g). Eight animals served as controls, in another eight animals, sepsis was induced by intra-peritonea! LPS 
injection. Twenty-four hours after induction of sepsis, the experimental animals were killed and RNA extracted from epididymal fat 
was investigated by real time PCR, in order to quantify expression of IL-6, IL-18, nerve growth factor (NGF), hypoxia-induced factor 
(HIF), adipsin and adiponectin in comparison to controls.
Results: Twenty-four hours after induction of sepsis, real time PCR revealed significant increases in the expression of IL-6 (500 fold), 
NGF (10 fold), TNF (5 fold) and HIF (3 fold), while there were significant decreases in the expres- sion of IL-18 (0.4 fold), adipsin 
(0.15 fold) and adiponectin (0.2 fold). Conclusions: These results show that white adipose tissue is an organ sys- tern which actually 
suffers from hypoxia during sepsis. It responds by a marked increase in the expression of pro-inflammatory cytokines. At the same 
time, the expression of anti-inflammatory cytokines as well as the expression of adipsin and adiponectin is reduced. Thus, we 
propose the hypothesis that white adipose tissue may be an important contributor to the pathophysiol- ogy of sepsis.
Reference:
1 Trayhum P and Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition 2004; 92: 347-355.
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INTRODUCTION
II has recently been established that white adipose tissue, 
besides its metabolic function in storing and releasing fatty 
acids, has a major role in secreting a variety of hormones 
and protein factors which are referred to as adipokines <11 
In particular, it has been suggested that adipose tissue 
releases pro-inflammatory cytokines, e g. IL-6, in response 
to hypoxia. Thus we felt tempted to investigate whether 
adipokine expression relates to sepsis in an animal model
METHODS
After obtaining a Home Office licence, we investigated 
thirty-two healthy, non-obese male mice (body wt. 25-28 g). 
Eight animals served as controls; in eight animals, sepsis 
was induced by intra-peritoneal IPS injection (25 pg/g body 
wt), in another eight animals by caecum ligature/puncture 
(CLP) and eight animals were sham-operated Twenty-four 
hours after induction of sepsis, the experimental animals 
were killed and RNA extracted from the epididymal fat pads. 
Real time PCR was used to quantify expression of IL-6, 
TNFa, IL-18, MCP-1, nerve growth factor (NGF), hypoxia- 
induced factor (HIF-1a), adipsin, adiponectin and leptin, in 
comparison to controls.
RESULTS
Twenty-four hours after induction of sepsis by LPS, real 
time PCR revealed substantial increases in the expression 
of IL-6 (500-fold), MCP-1 (55-fold). NGF (10-fold), TNFa (5- 
fold) and HIF-10 (3-fold), while there were significant 
decreases in the expression of IL-18 (2.5-fold), adipsin (6- 
fold) and adiponectin (5-fold). The results in the CLP-group 
were qualitatively similar
CONCLUSIONS
These results show that white adipose tissue is an organ 
system which responds to sepsis by a marked increase in 
the expression of pro-inflammatory cytokines. At the same 
time, the expression of anti-inflammatory cytokines as well 
as the expression of adipsin and adiponectin (anti­
inflammatory) is reduced. Thus, we propose the hypothesis 
that white adipose tissue may be an important contributor to 
the pathophysiology of sepsis, and that this may relate, at 
least in part, to hypoxia within the tissue.
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Abstract The proposition that white adipose tissue is 
involved in the inflammatory response and metabolic 
dysregulation of endotoxaemia has been examined. Mice 
were injected with iipopolysaccharidc (LPS; 25 mg/kg) and 
epididymal, perirenal and subcutaneous adipose tissue 
removed 4 or 24 h later. The expression of genes encoding 
key inflammation-related adipokines was measured by real­
time polymerase chain reaction. At 24 h after the 
administration of LPS, there was no change in leptin 
mRNA level, and adiponectin mRNA fell. However, major 
increases in TNFa, MCP-1 (up to 40-fold) and IL-6 (up to 
250-fold) mRNA levels were evident; a substantial eleva­
tion in these mRNAs occurred by 4 h, and adipose tissue 
IL-6 protein also increased (three- to eightfold). At 24 h, the 
responses in the subcutaneous depot were much lower than 
in epididymal and perirenal adipose tissue, but at 4 h, the 
subcutaneous tissue showed major increases in IL-6, MCP- 
1 and TNFa gene expression. In contrast to the inflamma­
tory adipokines, the mRNA level of two macrophage 
markers, F4/80 and MAC-1, was unaltered in adipose
M. Leuwer (R]) • 1. Welters • A. Rushton • H. Bao 
Critical Care Research Unit, School of Clinical Sciences, 
University of Liverpool, University Clinical Departments, 
Duncan Building,
Liverpool 1.69 3GA, UK 
e-mail: mleuwer@livcrpool.ac.uk
L. Hunter • P. Trayhum
Obesity Biology Research Unit, School of Clinical Sciences, 
University of Liverpool, University Clinical Departments, 
Duncan Building,
Liverpool L69 3GA. UK
G. Marx
University Clinic for Anaesthesiology and Intensive Care, 
University of Jena,
Jena, Germany
tissue during endotoxaemia. Expression of the hypoxia- 
sensitive transcription factor, HIF-lo, gene was increased 
at both 4 and 24 h, and HIF-1 a protein was elevated at 4 h, 
suggesting that the tissue was hypoxic. It is concluded that 
white adipose tissue may play an important role in the 
production of inflammatory mediators in endotoxaemia.
Keywords Adipokines • Adipose tissue • Endotoxaemia • 
IL-6 • Inflammation • Sepsis
Introduction
Sepsis, septic shock and endotoxaemia are systemic 
inflammatory states that affect most organs of the body, 
including white adipose tissue, and glucose metabolism and 
lipolytic capacity are particularly affected [21, 43]. It has 
been demonstrated that obese patients have a worse 
outcome from critical illness than non-obese individuals 
[33, 55]. To date, this has mainly been regarded as a result 
of difficulties in and complications of ventilation as well as 
an increase in the incidence of comorbidities such as 
diabetes and cardiac disease. While it is well established 
that, in obesity [54], as well as dining endotoxaemia and 
sepsis, lipolysis is altered and glucose utilisation is 
impaired [25], it has recently become clear that the potential 
mediatory role of white adipose tissue (WAT) is not 
confined to glucose and fat metabolism. WAT has become 
recognized as a major endocrine and secretory organ which 
contributes to inflammation-related diseases in obesity, 
such as the metabolic syndrome, by the secretion of protein 
mediators and signalling factors called adipokines [ 16, 34, 
46],
In obesity, the plasma concentration of a number of 
adipokines and proinflammatory markers expressed and
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released by adipocytes has been shown to rise as adipose 
tissue mass expands. These include cytokines (e.g. IL-6, IL- 
10), chemokines (e.g. IL-8, MCP-1, MIF) and acute-phase 
proteins (e.g, haptoglobin, serum amyloid A) as well as 
inflammation-related adipokines such as leptin and nerve 
growth factor (NGF) [16, 34, 45, 46], It has been suggested 
that these inflammatory changes may reflect hypoxia within 
die growing adipose tissue mass [46], and it is well 
recognised that in organs such as heart, kidneys and gut, 
hypoxia can induce the syndiesis of cytokines and 
inflammatory mediators [40]. Sepsis is considered to he a 
state of generalised microvascular dysfunction with a 
consequent decrease in oxygen delivery, which is associat­
ed widi tissue hypoxia and organ dysfunction [10]. Tire key 
intracellular pathway in hypoxia-induced metabolic 
changes involves activation of the transcription factor, 
H1F-1 [7, 39, 40], Activation ofHIF-1, through stabilisation 
of the HIF-lot subunit, during hypoxia triggers expression 
of glycolytic enzymes and membrane glucose transporters, 
such as GLUT-1 [7].
Previous studies have indicated that inflammation 
induced by lipopolysaccharide (LPS) and other agents 
leads to an increase in leptin expression and circulating 
levels in experimental animals [11, 12, 37], and increased 
circulating levels of the honnone have been observed in 
inflammatory conditions in humans [1, 4, 6, 44], Evidence 
has also been presented for increases in IL-6 expression in 
humans during experimentally induced inflammation [1, 
19], In the present study, we hypothesized that in 
endotoxaemia there is a major activation of tire inflamma­
tory response in adipose tissue, key inflammatory adipo­
kines contributing to the metabolic dysregulation 
characteristic of endotoxaemia and sepsis. A murine model 
of endotoxaemia was used to study tire expression in both 
internal and subcutaneous adipose tissue of a series of 
inflammation-related adipokines. Evidence for the induc­
tion of adipose tissue hypoxia was sought through 
measurement of HIF-lot.
Materials and methods 
Animals and tissue collection
All experiments were carried out on 8- to 10-week-old male 
C57BL/6J mice (Charles River, UK). The care of tire mice 
and all experimental procedures were approved by the UK 
Home Office and were conducted in accordance with the 
appropriate Project License. LPS (Escherichia coli 0 111: 
B4, Sigma-Aldrich) was injected intraperitoneally (ip) 
under general anaesthesia (2% isoflurane in N3O/O2) at a 
dose of 25 mg/kg. Control animals were administered 
equivalent volumes of normal saline, ip. All animals
Springer
received 1 ml of normal saline subcutaneously (sc) to 
compensate for fluid losses. Mice were housed in separate 
cages post-procedures and maintained in the same temper­
ature-controlled conditions with free access to standard 
laboratory chow and water. All mice were killed at 4 or 
24 h after injection of LPS by cervical dislocation. A 24- 
h time point is commonly used in studies on LPS-induccd 
endotoxaemia [12], providing a sufficient period for a 
severe response to be established, while 4 h [11, 37] was 
used to investigate acute effects. The eptdidymal, subcuta­
neous and perirenal fat depots were removed and immedi­
ately frozen in liquid nitrogen.
Real-time polymerase chain reaction
Total RNA was extracted from adipose tissues with Trizol 
reagent (Invitrogen, UK), and 1 pg of DNase I-treated 
RNA was reverse transcribed using a Reverse-iT™ 1st 
Strand Synthesis Kit (Abgene, UK) in the presence of 
anchored oligo dT in a total volume of 20 pi.
Real-time polymerase chain reaction (PCR) reactions 
were carried out in a final volume of 12.5 pi consisting of 
12.5-50 ng of reverse transcribed cDNA mixed with 
optimal concentrations of primers and probe and qPCR™ 
Core kit (Eurogentec, UK) in 96-well plates on a Mx3005P 
detector (Stratagene, USA). The primer and probe sets were 
designed using Primer Express software (Applied Biosys­
tems) or Beacon Designer (Biosoft, USA) and synthesized 
commercially (Eurogentec). The sequence of primers and 
probes is shown in Table 1.
Typically, the amplification started with 10 min at 95°C 
and then 40 cycles of the following: 15 s at 95°C and 1 min 
at 60°C. (5-actin was used as an endogenous reference. 
Relative quantitation values were expressed using tire 
2~AACt mBt]laij (scc user bulletin #2, ABI Prism 7700, 
Applied Biosystems) as fold changes in the target gene 
normalized to the reference gene and related to the 
expression of tire controls. The PCR efficiency in all rans 
was close to 100%, and all samples were analyzed in at 
least duplicate.
Measurement of protein by enzyme-linked immunosorbent 
assay
The total amount of HIF-1k in adipose tissue homogenates 
was measured hy enzyme-linked immunosorbent assay 
(ELISA) (R & D Systems, UK) as previously described 
[51]. Tire adipouectin, IL-6 and MCP-1 content of adipose 
tissue homogenates was also measured using commercial 
ELISAs, according to the manufacturer’s protocol. For 
adiponectin (R & D Systems), the stated minimal detectable 
amount was 3 pg/ml, and the interassay coefficient of 
variation was 6%. For 11-6 (RayBiotech, USA), the minimal
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Table 1 Primer and probe sequences used in real time PGR
Gene Sequence 5-3'
Adiponectin Forward ACGACCTCATTCTTTTTAAGCTATCC
Reverse TCCCCACGTGAGACCCCTACCCTT
Probe CCGGGTTCCACTTCTTTGTC
Adipsin Forward ACGACCTCATTCTTTTTAAGCTATCC
Reverse CCGGGTTCCACTTCTTTGTC
Probe TCCCCACGTGAGACCCCTACCCTT
(3-uctin Forward CAAGAAGGAAGGCTGGAAAAG
Reverse ACGGCCAGGTCATCACTATTG
Probe ACGAGCGGTTCCGATGCCCTG
F4/80 Forward AAGACTTGATACTCCAAAGTGAGC
Reverse GAAGGAAGCATAACCAAGATCCC
Probe CCCTGCACTGCTTGGCATTGCTGT
HIF-la Forward CAAGTCAGCAACGTGGAAGGT
Reverse CTGAGGTTGGTTACTGTTGGTATCA
Probe TTCACTGCACGGGCCATATTCATGTC
IL-6 Fonvard CATCTGCTGGCCTTCTCCAA
Reverse CAGGCTCTCTGGCTTCTG
Probe AGCTG CTCCCTGCCTCAGACCAGTG
IL-18 Forward GGCCTCTATTTGAAGATATGAC
TGATT
Reverse CCTCTAGGCTGGCTATCT1TATA
CATACT
Probe TGACTGTAGAGATAATGCACCCC
GGACC
Leptin Fonvard CATCTGCTGGCCTTCTCCAA
Reverse ATCCAGGCTCTCTGGCTTCTG
Probe AGCTGCTCCCTGCCTCAGACCAGTG
MAC-1 Forward GAATGGATTGTGCTATTTGTTCGG
Reverse CGGAGCCATCAATCAAGAAGAC
Probe TCCAACCTGCTGAGGCCGCCC
MCP-1 Forward GGCTCAGCCAGATGCAGTTAA
Reverse CCTACTCATTGGGATCATCTTGCT
Probe CCCCACTCACCTGCTGCTACTCA
TTCA
MT2 Fonvard CTTCTTGTCGCTTACACCGTT
Reverse AGCAGCACTGTTCGTCACTTC
NGF Fonvard GCCAAGGACGCAGCTTTCTAT
Rev AGTGATCAGAGTGTAGAACAACA
TGGA
Probe CTGGCCGCAGTGAGGTGC
TNFa Forward CCCAGACCCTCACACTCAGATC
Reverse GCCACTCCAGCTGCTCCTC
Probe TAGCCCACGTCGTAGCAAACCAC
CAAG
detectable quantity was 6 pg/ml and the interassay 
coefficient of variation <12%, while for MCP-1 (RayBio- 
tech), the values were <3 pg/ml and <12%, respectively.
Statistical analysis
The statistical significance of differences between treated 
and control groups was assessed with Student’s t test for 
independent samples. P<0.05 was considered significant.
Results
Effect of EPS on adipokine expression 24 h after 
the induction of endotoxaemia
In order to induce severe endotoxaemia, a high dose of 
lipopolysaccharide was administered; the survival rate at 
4 h was 100%, while the 24 h survival rate was 61%. In tire 
first experiments, the mice were treated with EPS for 24 h 
and the epididymal, perirenal and subcutaneous adipose 
tissue depots examined. Tissues were only analysed for 
those animals that survived. EPS administration had no 
significant effect on leptin mRNA level in tire epididymal 
WAT; nor was there any change in metalliothein-2 mRNA 
(Fig. 1). However, EPS induced a fivefold fall in 
adiponectin mRNA level, and there was a similar reduction 
in the level of both adipsin and 1L-18 mRNA (Fig. 1). In 
contrast to these genes, there were increases in mRNA level 
for 1L-6, MCP-1, NGF and TNFoc (Fig. 1). The increase in 
NGF mRNA was small (twofold), hut MCP-1 and TNFct 
mRNA levels increased by 24- and 18-fold, respectively, 
while IL-6 mRNA level increased as much as 250-fold.
Examination of the perirenal adipose tissue depot gave 
broadly similar results, with reductions in adipsin and 
adiponectin mRNA levels (Fig. 1). However, the changes 
were less substantial than with the epididymal depot, tire 
decreases in IL-18 and adiponectin mRNA levels being 
statistically insignificant. Leptin was again unchanged 
following treatment with EPS. TNFct mRNA level in­
creased by eightfold, MCP-1 by 40-fold and the largest 
increase (120-fold) was with IL-6 (Fig 1).
The results obtained with the subcutaneous adipose 
tissue were less dramatic than with either the epididymal 
or perirenal depots. Adiponectin mRNA level fell fivefold, 
but there were no significant changes with leptin, adipsin, 
IL-18, NGF, TNFct and MT-2 (Fig. 1). The lack of change 
in TNFa mRNA is noteworthy given the increases 
observed in tire other two fat depots. MCP-1 and IL-6 
mRNA levels were, however, elevated in subcutaneous fat 
in response to LPS, the increases being four- and 20-fold, 
respectively (Fig. 1).
Effect of LPS on adipokine expression 4 h after 
the induction of endotoxaemia
To assess tire rapidity of tire response to LPS, studies were 
next undertaken at 4 h after injection. Epididymal, perirenal 
and subcutaneous adipose tissue depots were again examined. 
In the epididymal depot at 4 h, there were no significant 
changes in adipsin, adiponectin, IL-18 and MT-2 mRNA 
levels (Fig. 2). There were, however, small, but statistically 
significant, increases in leptin (fourfold) and NGF (3.8-fold) 
mRNAs. Substantial increases were observed for TNFa (20-
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Fig. 1 Adipokine gene expres­
sion in endotoxaemia in mice. 
Mice were injected with EPS to 
induce severe sepsis (closed 
bars) and adipose tissue depots 
removed 24 h later; control mice 
(open bars) received a saline 
injection. The level of each 
adipokine mRNA was measured 
in epididymal (Epi), perirenal 
(Peri) and subcutaneous (Sub) 
depots by real-time PCR and 
normalized to 0-actin relative to 
the untreated control group (=1). 
IL-6 Interleukin 6, IL-I8 inter­
leukin 18, MCP-I monocyte 
chemoattractant protein 1, MT2 
metallothionein 2, NGF nerve 
growth factor, TNFa tumour 
necrosis factor a. Results are 
given as mean values+SH for 
five to six mice in each group. 
*P<0.05. **/><0.01, ***/•< 
0.001 compared with controls
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Fig. 2 Acute effects of endo- 
toxaemia on adipokine gene 
expression in mice. Mice were 
injected with LPS to induce 
severe sepsis (closed bars) and 
adipose tissue depots removed 
4 h later, control mice (open 
bars) received a saline injection. 
The level of each adipokine 
mRNA was measured in epidid- 
ymal (Epi), perirenal (Peri) and 
subcutaneous (Sub) depots by 
real-time PCR and normalized 
to (3-actin relative to the un­
treated control group (=1). 
Results are given as mean val- 
ues±SF. for five to six mice in 
each group. *7><0.05, **P< 
0.01, ***/><0.001 compared 
with controls
£) Springer
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fold) and particularly MCP-1 (250-fold) and IL-6 (500-fold) 
mRNA. A broadly similar pattern was observed in the 
perirenal depot, although in this case, there was no change in 
leptin mRNA level. The largest changes were again with 
MCP-1 and IL-6 mRNA, the levels of which were increased 
by 35- and 78-fold, respectively (Fig. 2). TNFa level 
increased 23-fold, and a modest increase (fourfold) was 
observed with NGF.
In the subcutaneous adipose tissue, there were no 
changes in mRNA levels for IL-18, leptin and MT-2 
(Fig. 2). There was, however, an approximately 50% 
reduction in mRNA levels for adipsin and adiponectin. 
NGF and TNFa mRNA levels increased moderately, by 
four- and 17-fold, respectively. Very major changes were 
observed with MCP-1, the mRNA level of which increased 
250-fold, and with IL-6 where the increase was >1,000-fold 
(Fig. 2).
White adipose tissue adipokine levels
The adipokine protein content was measured by ELISA in 
the epididymal and subcutaneous fat depots for the two 
inflammatory adipokines which exhibited the largest 
changes in mRNA level. IL-6, which showed the greatest 
elevation in mRNA, was increased in both the epididymal 
and subcutaneous fat at 4 and 24 h after the injection of 
LPS (Fig. 3). The increase in the epididymal depot was 
between five- and eightfold, while in the subcutaneous 
tissue the rise was between three- and eightfold.
In contrast to IL-6, there was no significant increase in 
MCP-1 protein in either tissue at 24 h. However at 4 h, the 
amount of MCP-1 was approximately eightfold greater in 
the epididymal fat and twofold greater in the subcutaneous 
depot (Fig. 3). For adiponectin, only in the epididymal 
depot after 24 h of treatment with LPS was there a
Fig. 3 Adipokine levels in adi­
pose tissue in endotoxaemia in 
mice. Mice were injected with 
LPS to induce severe sepsis 
(closed bars) and adipose tissue 
depots removed 4 or 24 h later; 
control mice (open bars) re­
ceived a saline injection. Adi­
pokine proteins were measured 
in the epididymal (Epi) and 
subcutaneous (Sub) depots by 
ELISA. Results are given as 
mean values t SE for three to six 
mice in each group. *P<0.05, 
**P<0.01 compared with con­
trols
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significant fall in the protein, refiecting the changes in the 
mRNA level. However, paradoxically the adiponectin level 
in the subcutaneous depot was actually increased, rather 
than decreased, at both 4 and 24 h in the LPS-treated mice.
Macrophage marker expression
To assess whether the increases in the expression of key 
inflammatory adipokine genes, particularly MCP-1, 
reflected an infiltration of macrophages into adipose tissue, 
the mRNA level of two macrophage markers was exam­
ined. The markers were F4/80 and MAC-1, and these were 
examined in 4 and 24 h LPS-treated mice and in all three 
WAT depots. In no case was there a statistically significant 
increase in F4/80 and MAC-1 mRNA level (Fig. 4). Indeed, 
in one case, the perirenal tissue treated for 24 h, the level of 
both mRNAs was significantly decreased. F4/80 mRNA 
level was also decreased in the epididymal depot at 24 h.
HlF-la as an index of hypoxia
In the final investigation, the effect of LPS treatment on the 
key molecular index of cellular oxygen deficiency, the 
hypoxia-sensitive transcription factor HIF-1 a, was exam­
ined. The expression and protein level of HlF-la was 
determined in both the epididymal and subcutaneous 
adipose tissue depots. At 4 h after the treatment with LPS, 
there was a three- to fourfold increase in HIF-1 a mRNA in 
each depot, and importantly, this was accompanied by a
two- to threefold increase in HIF-1 a protein (Fig. 5). HIF- 
1 a mRNA level was also twofold higher in both depots at 
24 h, but at this later time point, there was no significant 
change in HIF-1 a protein (Fig. 5).
Discussion
The present study demonstrates that there are major 
changes in the expression of key adipokine genes in each 
of the main white adipose tissue depots in mice following 
the induction of endotoxaemia. The expression of several 
major inflammation-related adipokines was examined, and 
by far the largest response was observed with IL-6 and 
MCP-1. Adipose tissue produces large amounts of IL-6 
and is considered to be a substantial contributor to 
circulating levels of this cytokine [9, 26], Plasma IL-6 
levels are increased in endotoxaemia as well as sepsis, and 
it seems likely that adipose tissue contributes directly to this 
[1, 13, 19], particularly since in the present study the 
amount of IL-6 in the fat depots was increased alongside 
the increase in mRNA level. Nevertheless, it should be 
noted that the increase in protein was much less than the 
changes in mRNA level, although this could reflect rapid 
release of IL-6 from the tissue once synthesised.
The chemokine MCP-1 shows increased expression in 
obesity, like IL-6, and is linked to the recruitment of 
macrophages within tissues, including adipose tissue. 
Indeed, in obesity there is a major infiltration of macro-
Fig. 4 Expression of macro­
phage markers in adipose tissue 
in endotoxaemia in mice. Mice 
were injected with LPS to in­
duce endotoxaemia (closed 
bars) and adipose tissue depots 
removed 4 or 24 h later control 
mice (open bars) received a 
saline injection. The level of 
each macrophage marker 
mRNA was measured in epidid­
ymal (Epi), perirenal (Peri) and 
subcutaneous (Sub) depots by 
real-time PCR and normalized 
to p-actin relative to the un­
treated control group (=1). 
Results are given as mean val- 
ues±SE for five to six mice in 
each group. */><0.05, *,P< 
0.01, ***P<0.001 compared 
with controls
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Fig. 5 HIF-la gene expression 
and protein levels in adipose 
tissue in endotoxaemia in mice. 
Mice were injected with LPS to 
induce endotoxaemia (closed 
bars) and adipose tissue depots 
removed 4 or 24 h later, control 
mice (open bars) received a 
saline injection. HIF-la mRNA 
(a) and protein levels (b) were 
measured in the epididymal 
(Epi) and subcutaneous (Sub) 
depots by real-time PCR, the 
level being normalized to f$- 
actin relative to the untreated 
control group (=1), and by 
ELISA, respectively. Results are 
given as mean values±SE for 
five to six mice in each group. 
•PcO.OS, •*P<0.01 compared 
with controls
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phages into adipose tissue [52, 54], Since the mRNA level 
of two macrophage markers—F4/80 and MAC-1—did not 
increase in any of the three adipose tissue depots examined, 
either at 4 or 24 h after the administration of LPS, it is 
unlikely that there was an infiltration of immune cells 
during the duration of endotoxaemia in the present work. 
The increased MCP-1 expression suggests that macrophage 
reemitment into adipose tissue may well occur long-term; 
however, in contrast to IL-6, no sustained elevation in 
MCP-1 protein levels was evident in adipose tissue 
homogenates following LPS treatment.
In addition to macrophage infiltration, MCP-1 has been 
associated with the development of insulin resistance [38]. 
This is also the case with IL-6 and TNFa [17, 20, 27, 35]. 
Thus, the major stimulation of the expression of these three 
factors in response to LPS suggests that adipose tissue may 
contribute to insulin insensitivity and the dysregulation of 
glucose homeostasis in infection. TNFa is a pleiotrophic 
pro-inflammatory cytokine, and its actions in adipose tissue 
include the stimulation of lipolysis and of apoptosis [31, 
36], It also has a major effect on the expression of other 
inflammation-related adipokines including the strong upre- 
gulation of IL-6 and MCP-1 production [49, 50],
In marked contrast, adiponectin expression was down- 
regulated in all three adipose tissue depots 24 h after the 
administration of LPS. There was also a significant 
reduction in adiponectin mRNA in the subcutaneous depot 
at 4 h. Adiponectin. which is a key adipocyte-derived 
hormone, has multiple physiological effects, and these 
include anti-inflammatory and insulin sensitising actions 
[5, 28, 29, 56], Thus, a fall in adiponectin expression may
add to the upregulation of IL-6, MCP-1 and TNFa 
expression in leading to a major pro-inflammatory response 
and insulin resistance in endotoxaemia. However, although 
adiponectin protein level decreased in the epididymal depot 
at 24 h (the absence of a change at 4 h may reflect the time 
delay between alterations in gene transcription and subse­
quent protein synthesis), in the case of the subcutaneous 
depot, there was a paradoxical increase in the amount of the 
hormone. We have no satisfactory explanation for this 
anomaly, although it may indicate that adiponectin is less 
readily released from the subcutaneous adipose tissue in 
endotoxaemia.
Furthermore, low adiponectin levels observed in obesity 
[3] as a state of low-grade chronic inflammation are 
associated with increased insulin resistance [5, 56]. Stress- 
induced hyperglycaemia frequently occurs in infection and is 
associated with an adverse outcome [14, 48]. Elevated 
TNFa levels, increased MCP-1 production as well as low 
adiponectin may act in concert to induce and to maintain 
hyperglycaemia in critical illness. Although the present study 
does not reveal the extent to which adipose tissue might 
contribute quantitatively to alterations in circulating levels of 
cytokines and chemokines in endotoxaemia, overall, our 
results suggest a role for the tissue in the changes in glucose 
metabolism associated with infection. It is emphasised that 
since in the 24-h studies there was a distinct mortality rate 
and that only tissues from surviving animals were investi­
gated, there could be a link between the gene expression 
profile and the protective survival response.
Expression of the complement-related factor, adipsin, 
also fell during endotoxaemia. Leptin, on the other hand.
£) Springer
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showed no changes in gene expression. This is in contrast 
with previous studies in experimental animals and in 
humans where an upregulation has been described [1, 12, 
37]. However, the previously reported changes in leptin 
mRNAwere very small, particularly in comparison with the 
dramatic changes in IL-6 and MCP-1 mRNA level.
Small increases in NGF mRNA level were observed in 
the epididymal and perirenal depots but not in the 
subcutaneous tissue. This target-derived ncurotrophin is 
also involved in the inflammatory response, its expression 
and secretion from both murine and human adipocytes 
being stimulated by TNFct [30, 49]. The low molecular 
weight cysteine-rich, metal-binding protein metallothionein 
showed little response to LPS except in the perirenal depot 
where there was a small increase at 24 h. Similarly, there 
was little change in the expression of IL-18; this pro- 
inflammatory cytokine plays an important role in innate and 
acquired immunity, and its expression in adipocytes [41, 
53] has been shown to be strongly upregulated by TNFct 
[53].
Certain depot-specific responses to LPS were evident in 
the present study. Of the three adipose tissue sites 
examined, the largest response was observed in the 
epididymal depot in the case of both IL-6 and TNFct (at 
24 h). Indeed, tire subcutaneous depot showed no increase 
in TNFct mRNA level at 24 h. In this context, it has been 
shown that subcutaneous adipose tissue is affected to a 
lesser degree by sepsis-induced malperfusion than the 
splanchnic area and does not contribute to lactate produc­
tion during critical illness [25].
In addition to depot differences, there is the important 
question of which cells within adipose tissue may be 
responsible for alterations in adipokine/cytokine production 
in endotoxaemia. White fat consists of two major compo­
nents, mature adipocytes and the stromal-vascular fraction. 
The stromal-vascular fraction includes macrophages, fibro­
blasts, vascular endothelial cells and preadipocytes. Adipo­
cytes are able to express each of the inflammation-related 
signals examined in the present study (see [46, 47]). 
However, while the key cytokines and chemokines are also 
expressed by macrophages, adipocytes alone are responsi­
ble for adiponectin and leptin production.
It could be hypothesized that during endotoxaemia, 
macrophages infiltrate adipose tissue, causing further 
inflammatory damage and substantially contributing to 
mediator production. This would imply that immigrating 
immune cells are mainly responsible for the changes 
observed. However, as noted above, the mRNA level of 
two specific macrophage markers did not increase in WAT 
and even decreased in tire case of the perirenal depot at 
24 h. This suggests that mature adipocytes may be the key 
site of the response to LPS. Indeed, adipocytes express the 
Toll-like receptor 4 through which LPS exerts its inflam­
matory effect [22, 42], Irrespective of the cell type 
involved, adipose tissue can be regarded as a key 
inflammatory organ, which may contribute to the systemic 
respoitse observed during systemic infection by generating 
and releasing inflammatory mediators into the circulation. 
However, the possibility that resident macrophages arc 
activated and may contribute to adipokinc/cytokirre pro­
duction in tire various adipose tissue depots in endotox­
aemia, without increased immune cell infiltration, cannot be 
excluded.
It has recently been proposed that the inflammation that 
occurs in adipose tissue in obesity may, at least in part, be a 
response to relative hypoxia in groups of adipocytes distant 
from the vasculature [46], Evidence in support of this 
hypothesis is emerging [15, 32, 57], and hypoxia has been 
shown to directly increase the expression and release of 
inflammation-related adipokines such as leptin, IL-6, MIF 
and VEGF in murine and human adipocytes, while 
adiponectin with its anti-inflammatory action is decreased 
[8, 15, 23, 51,57]. We were therefore interested in whether 
hypoxia might underlie the changes in adipokine expression 
in endotoxaemia. Increases in the mRNA encoding the 
hypoxia-sensitive transcription factor, HIF-lcx, were evi­
dent following administration of LPS, and increased HIF- 
1 a protein was found at 4 h. This suggests that at least in 
the early stages of endotoxaemia, hypoxia may occur in 
adipose tissue. The changes at the protein level were not 
sustained by 24 h, implying that any hypoxia may have 
been transitory. Further work is warranted on hypoxia in 
adipose tissue in severe infection and whether it underlies 
the changes in adipokine expression.
A high dose of LPS was employed to induce endotox­
aemia, and it may also reflect sepsis. However, the LPS 
challenge may not adequately reproduce the complexity of 
human sepsis. In particular, investigators with an interest in 
peri-operative sepsis have increasingly used caecal ligation 
and puncture (CLP) as the model of choice. In a 
preliminary series of experiments with CLP in the same 
strain of mice, we were able to reproduce the changes in 
IL-6 mRNA levels found in the epididymal fat depot after 
LPS challenge. Here IL-6 mRNA levels were 87-fold 
higher than in control mice and sixfold higher than in 
sham-operated mice at 24 h (unpublished data). Apparently, 
CLP leads to qualitatively similar changes in IL-6 expres­
sion as LPS, suggesting that white adipose tissue is 
activated in septic shock as in endotoxaemia.
Clinical sepsis is commonly polymicrobial, but experi­
mentation involving bacterial products, such as LPS, may 
serve to characterize response patterns directed against one 
particular organism [18]. We therefore used LPS as the 
model of choice to examine the potential role of WAT 
during severe infection. The dose employed, although high, 
is within the range used in previous studies and elicited a
Cl Springer
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severe, acute, systemic inflammatory response in mice with 
all the symptoms of sepsis and septic shock [24], 
Importantly, the substantial increase in IL-6 and MCP-1 
gene expression in the subcutaneous adipose tissue at 4 h 
indicates a systemic response in WAT rather than an effect 
local to die i,p, site of injection. The mortality rate of 39% 
in our 24-h series of experiments reflects acute life- 
direatening gram-negative infection of a severity similar 
to diat occurring in human sepsis [2]. Further investigations 
using various models of sepsis are warranted to specify the 
role of WAT in infection caused by different organisms.
In conclusion, our results demonstrate that LPS chal­
lenge sufficient to mimic endotoxaemia leads to major 
changes in the expression of key adipokine genes in 
different adipose tissue depots of mice. Thus, white 
adipocytes (and preadipocytes) may well contribute directly 
to the most prominent features of infection—systemic 
inflammation and metabolic dysrcgulation. If this could be 
corroborated in studies involving human patients, it woidd 
allow a new interpretation of the positive correlation 
between body mass index and sepsis mortality as well as 
die development of novel approaches to treating insulin 
resistance in severe infection.
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